Study design informations |
Randomized controlled trials |
Is randomization appropriately performed? |
Are the groups comparable at baseline? |
Are there complete outcome data? |
Are outcome assessors blinded to the intervention provided? |
Did the participants adhere to the assigned intervention? |
Non-randomized controlled trials/observational studies |
Are the participants representative of the target population? |
Are measurements appropriate regarding both the outcome and intervention (or exposure)? |
Are there complete outcome data? |
Are the confounders accounted for in the design and analysis? |
During the study period, is the intervention administered (or exposure occurred) as intended? |
Information about statistical methods |
Is the minimum difference considered important to prove the intervention efficacy/effectiveness reported? |
Are the alpha and beta levels that define statistical significance reported and respected? |
What is the statistical method used to assess the intervention impact on the primary outcome? |
What is statistical the method used to assess the intervention impact on HIV prevalence/incidence? |
Did the authors report analyses to confirm that the statistical assumptions of the analysis were met or the goodness of fit of the model? |
Did the authors report a measure of precision alongside the impact measure? |
Is the design taken into account in the statistical analyses? |
Information about the mathematical methods |
Are the parameters to be estimated in the model specified? |
Are the uncertainties concerning these parameters evaluated? |
Are the different components of the model and their roles clearly defined? |
Are the different scenarios/processes/assumptions tested by the model clearly specified? |
Are the data and data sources specified? |
Are the states of the various model components clearly specified from data? |
Are the methods used to compute estimates specified? |